Treatment of experimental sepsis-induced immunoparalysis with TNF
Authors:
- Renate UrbaschekRURenate Urbaschek
- Karin WeiglKWKarin Weigl
- Marina A. FreudenbergMFMarina A. Freudenberg
- Daniela N. MännelDMDaniela N. Männel
- 1 January 2003
- journal article
- Published by Elsevier in Immunobiology
- Vol. 208 (4) , 381-389
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (EC142/3-2, Ma760/10, SPP 1110/FR 448/4, UR41/1-1)
This publication has 20 references indexed in Scilit:
- The Essential Role of Lipopolysaccharide-Binding Protein in Protection of Mice Against a Peritoneal Salmonella Infection Involves the Rapid Induction of an Inflammatory ResponseThe Journal of Immunology, 2001
- Tumor Necrosis Factor-Dependent Adhesions as a Major Protective Mechanism Early in Septic Peritonitis in MiceInfection and Immunity, 2001
- What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant?Surgery, 1999
- Interferon Gamma-1b in the Treatment of Compensatory Anti-inflammatory Response SyndromeArchives of internal medicine (1960), 1997
- Monocyte deactivation-rationale for a new therapeutic strategy in sepsisIntensive Care Medicine, 1996
- Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.Journal of Experimental Medicine, 1996
- Critical protective role of mast cells in a model of acute septic peritonitisNature, 1996
- Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infectionCell, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Sepsis and septic shock—A review of laboratory models and a proposalJournal of Surgical Research, 1980